San Mateo, CA, United States of America

Michael A Palladino


Average Co-Inventor Count = 1.7

ph-index = 6

Forward Citations = 592(Granted Patents)


Location History:

  • Foster City, CA (US) (1991 - 1992)
  • San Mateo, CA (US) (1987 - 1998)

Company Filing History:


Years Active: 1987-1998

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Michael A. Palladino: Innovator in Tumor Necrosis Factor Antagonists

Introduction

Michael A. Palladino is a distinguished inventor based in San Mateo, California. With an impressive portfolio of six patents, he has significantly contributed to the field of biomedical research, particularly in the development of tumor necrosis factor antagonists. These innovative therapies have the potential to transform the treatment landscape for various autoimmune diseases.

Latest Patents

One of Palladino's latest patents focuses on tumor necrosis factor antagonists and their therapeutic applications. These antagonists are designed to be administered in therapeutically effective doses, specifically to suppress inflammatory immune-potentiated events. The invention involves various classes of antagonists, with a preference for neutralizing antibodies targeted against tumor necrosis factor. This groundbreaking work highlights their utility in suppressing transplantation immunity and treating autoimmune diseases, underscoring Palladino’s commitment to advancing medical science.

Career Highlights

Michael A. Palladino has made significant strides in his career, particularly through his association with Genentech, Inc., a leading biotechnology company known for its innovation in pharmaceuticals. His work at Genentech has allowed him to explore cutting-edge therapeutic solutions and refine his expertise in immunology and drug development.

Collaborations

Throughout his career, Palladino has collaborated with esteemed colleagues such as Bharat B. Aggarwal and Mohamed R. Shalaby. These partnerships have facilitated a vibrant exchange of ideas and have contributed to the successful advancement of his research endeavors. Working alongside such talented individuals has further enriched his contributions to the field of biomedical innovation.

Conclusion

Michael A. Palladino stands out as a notable inventor in the realm of tumor necrosis factor antagonists. His innovative approaches and collaborative spirit have the potential to impact the treatment of autoimmune diseases significantly. As he continues his work at Genentech, the medical community eagerly anticipates the fruits of his labor and the advancements that will arise from his ongoing research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…